Rybelsus 3 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FHJHL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,572
Award facts
- Contract value 100% obligated
- $20,571.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $20,571.84 delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Rybelsus 3 mg tablets in quantities of 30 units. This firm fixed-price, non-competitive delivery order is scheduled for completion by September 29, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran healthcare systems through DLA's Medical Supply Chain. The company maintains an extensive portfolio of federal contract awards covering a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill medical procurement requirements for customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Rybelsus, a diabetes medication, exemplifies the company's role in supporting federal medical supply needs through the established prime vendor contract structure.
Quick answers
Who was awarded contract SPE2DB25FHJHL?
SPE2DB25FHJHL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FHJHL worth?
The government has obligated $20,572 on SPE2DB25FHJHL.
Is contract SPE2DB25FHJHL an order under another contract?
Yes. SPE2DB25FHJHL is a delivery order under SPE2DB24D2208, an indefinite delivery contract.
Was contract SPE2DB25FHJHL competed?
The extent of competition for SPE2DB25FHJHL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award